Few days ago I bought BRZE November 20, 2026 $30 Calls for $2.50 on the pullback. This week those calls are almost up 50%. That's not luck. That's what happens when you stop chasing the obvious AI names and start positioning where the smart money is quietly setting up before the move.
While retail is busy fighting over NVDA at the highs and arguing about AMD's next quarter, I'm doing two things at once: taking shots on beaten-down names with defined risk, and stacking structured notes that pay me double-digit yield no matter what the market does. That's the blueprint.
Starting June 16, This AI Lab Could Take Off Dramatically (Ad)
Time magazine recently named this lab "the most disruptive company in the world." It's not SpaceX or OpenAI. In fact, its annualized revenues have already surpassed both of these firms. And this 60-year Wall Street legend believes it's gearing up for a watershed product launch that could send its sales soaring even higher starting June 16. Click here to learn how you can access a "pre-IPO backdoor" into this firm for just $40 a share.
The Deal Breakdown — The BRZE Trade
Let me lay out exactly what hit last week:
Ticker: BRZE (Braze)
Strike: $30 calls
Expiration: November 20, 2026
Entry premium: $2.50 per contract
Current price: trading close to $3.65
Move: roughly +46% in one session
This is what asymmetric positioning looks like in real time. I didn't chase the name when it was ripping. I waited for a pullback in a customer engagement software stock that had been beaten up alongside the broader software meltdown. Cheap premium, defined risk, decent runway — that's the entire setup. On May 29, it's paying off because the market is starting to remember that not every software name is going to be killed by AI.
The Mechanics — Why This Works
The BRZE setup followed the same playbook every high-conviction options trade needs:
A hated, oversold name with a clear business model
Premium that's cheap relative to historical volatility
A multi-month window to let the thesis develop
Defined-risk structure so I know exactly what I'd lose
A specific entry on weakness, not chasing strength
Buying calls on pullbacks beats chasing breakouts every time. When you buy strength, you're paying full premium and hoping the move continues. When you buy weakness in a quality name, you're getting the same upside at a discount and only need a sentiment shift to pay off. The BRZE move on May 29, is exactly that — a relief rally on a name that got too cheap.
The Other Side of the Blueprint — Structured Notes
Here's where the high yield part of "High Yield Blueprint" actually lives. While I take occasional swing shots like BRZE, the core of my book is in structured notes. And in this market — with yields drifting higher and chip names looking exhausted — I'm buying more of them, not fewer.
What I'm doing right now:
Buying structured notes with 40-50% downside barriers on indexes and baskets
Targeting double-digit annual coupons paid monthly or quarterly
Layering maturities across 1, 2, and 3 years for steady income
Avoiding chasing crazy chip names at extended levels
Letting volatility work for me instead of paying for it
The chip names that everyone is in love with are exhausted. NVDA is down meaningfully from its highs. AMD and MU have rolled with it. Anyone buying these at the top is paying premium volatility prices and praying for direction. I'm doing the opposite — I'm getting paid a coupon to wait, and if the market chops sideways or drifts, I still win.
The Institutional Context
Walk into Goldman's private wealth desk, Morgan Stanley's family office channel, or JPM's private bank and ask what their best clients are buying right now. The answer is the same: structured notes with deep protection and rich coupons.
Why the wealthy love this structure right now:
Implied volatility is elevated on AI and semi names, making coupons fat
Rates are still high enough that the bond floor adds real cushion
Markets are choppy and directionless — perfect for income structures
Tax efficiency depending on the wrapper and account type
Defined risk profiles that pair well with concentrated equity positions
You're not gambling on direction — you're harvesting fear. When the market is jumpy and volatility is bid, structured notes are the cleanest way to monetize that nervousness without taking a directional view. The retail crowd is paying option premium. The smart money is selling them that premium through note structures.
The Risk Asymmetry
Let's compare the two sides of what I'm doing:
BRZE calls: risked $2.50 to potentially make $5, $10, or more if the stock runs
Structured notes: collect a 10-15% coupon as long as the underlying doesn't crash through a 40-50% barrier
Chip chasers: buying NVDA $50 below the highs hoping for another leg up with no protection
Cash holders: sitting on the sidelines getting nothing but money market yield
Defined-risk speculation plus high-yield income is the best of both worlds. I take limited shots on names where the asymmetry is screaming — like BRZE on a pullback — and I let the core of my book earn me cash flow regardless of direction. I never need the market to do anything specific to win.
Final Thoughts
Stop trying to be a hero at the top. Start getting paid to be patient. The chip names that everyone loves are exhausted. The easy AI money is over. What's left is volatility, headlines, and a lot of late buyers wondering why their P&L isn't growing anymore.
The blueprint is simple:
Take small, defined-risk shots on beaten-down names with real businesses
Build the core of your book in structured notes that pay you yield
Stop chasing whatever just ripped 50%
Let asymmetric setups and high coupons compound quietly
The BRZE trade is up almost 50% in 24 hours. The notes are paying me whether the market rips or rots. Meanwhile, the chip chasers are still waiting for NVDA to take out its highs. Two completely different games — one of them is rigged in my favor.
Get paid to wait. Take shots on fear. Skip the crowded trade. That's the entire blueprint.
Disclaimer: This content is for educational purposes only and does not constitute financial advice. Options trading involves risk, and not all trades will be profitable. Always manage risk responsibly.

